Rash severity in herpes zoster: Correlates and relationship to postherpetic neuralgia

Journal of the American Academy of Dermatology

Volumn 46, Issue 6, 2002, Pages 834-839

  Nagasako, Elna M ^a   Johnson, Robert W ^b   Griffin, David R J ^c   Dworkin, Robert H ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; FAMCICLOVIR;

ADULT; AGE; ARTICLE; DERMATOME; DISEASE SEVERITY; FEMALE; FOLLOW UP; HERPES ZOSTER; HUMAN; IMMUNOCOMPETENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PAIN; PAPULE; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RASH; RISK FACTOR; STATISTICAL ANALYSIS;

EID: 0036621074     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.120924     Document Type: Article

References (28)

1. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965;58:9-20.
2. McCrary ML, Severson J, Tyring SK. Varicella zoster virus. J Am Acad Dermatol 1999;41:1-14.
3. Dworkin RH, Schmader KE. The epidemiology and natural history of herpes zoster and postherpetic neuralgia. In: Watson CPN, Gershon AA, editors. Herpes zoster and postherpetic neuralgia. 2nd revised and enlarged ed. New York: Elsevier Sciences; 2001. p. 39-64.
4. Dworkin RH, Boon RJ, Griffin DRG, Phung D. Postherpetic neuralgia: impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients. J Infect Dis 1998;178(Suppl 1):S76-80.
5. Harrison RA, Soong S, Weiss HL, Gnann JW, Whitley RJ. A mixed model for factors predictive of pain in AIDS patients with herpes zoster. J Pain Symptom Manage 1999;17:410-7.
6. Whitley RJ, Weiss HL, Soong SJ, Gnann JW. Herpes zoster: risk categories for persistent pain. J Infect Dis 1999;179:9-15.
7. Bowsher D. The lifetime occurrence of herpes zoster and prevalence of post-herpetic neuralgia: a retrospective survey in an elderly population. Eur J Pain 1999;3:335-42.
8. Battock TM, Finn R, Barnes RMR. Observations on herpes zoster: 1. residual scarring and post-herpetic neuralgia; 2. handedness and the risk of infection. Br J Clin Pract 1990;44:596-8.
9. Bowsher D. Postherpetic neuralgia in older patients: incidence and optimal treatment. Drugs Aging 1994;5:411-8.
10. Bowsher D. The effects of acyclovir therapy for herpes zoster on treatment outcome in postherpetic neuralgia: a randomised study. Eur J Pain 1994;15:9-12.
11. Nurmikko TJ, Bowsher D. Somatosensory findings in postherpetic neuralgia. J Neurol Neurosurg Psychiatry 1990;53:135-41.
12. Higa K, Mori M, Hirata K, Hori K, Manabe H, Dan K. Severity of skin lesions of herpes zoster at the worst phase rather than age and involved region most influences the duration of acute herpetic pain. Pain 1997;69:245-53.
13. Dworkin RH, Nagasako EM, Johnson RJ, Griffin DRJ. Acute pain in herpes zoster: the famciclovir database project. Pain 2001;94: 113-9.
14. Tyring S, Barbarash RA, Nahlik JE, Cunningham A, Marley J, Heng M, et al. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995;123:89-96.
15. Degreef H. Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients. Int J Antimicrob Agents 1994;4:241-6.
16. Candaele M, Candaele D. Famciclovir: confirmed efficacy of 250 mg t.i.d. for the treatment of herpes zoster (HZ) infection. Presented at International Conference on Antiviral Research, Charleston, SC, Feb 27-March 4, 1994.
17. Ashton RE. Efficacy of once and twice daily famciclovir for the treatment of acute herpes zoster. Presented at the European Congress on Antimicrobial Chemotherapy, Glasgow, UK, May 11-17, 1996.
18. Helgason S, Sigurdsson JA, Gudmundsson S. The clinical course of herpes zoster: a prospective study in primary care. Eur J Gen Pract 1996;2:12-6.
19. Galil K, Choo PW, Donahue JG, Platt R. The sequelae of herpes zoster. Arch Intern Med 1997;157:1209-13.
20. Wood MJ, Kay R, Dworkin RH, Soong SJ, Whitley RJ. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis 1996;22:341-7.
21. Dworkin RH, Carrington D, Cunningham A, Kost R, Levin M, McKendrick M, et al. Assessment of pain in herpes zoster: lessons learned from antiviral trials. Antiviral Res 1997;33:73-85.
22. Dworkin RH, Perkins FM, Nagasako EM. Prospects for the prevention of postherpetic neuralgia in herpes zoster patients. Clin J Pain 2000;16:S90-100.
23. Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995;39:1546-53.
24. Tyring SK, Beutner KR, Tucker BA, Anderson WC, Crooks RJ. Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch Fam Med 2000;9:863-9.
25. Watson CPN, Deck JH, Morshead C, Van der Kooy D, Evans RJ. Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain 1991;44:105-17.
26. Rowbotham MC, Yosipovitch G, Connolly MK, Finlay D, Forde G, Fields HL. Cutaneous innervation density in the allodynic form of posthereptic neuralgia. Neurobiol Dis 1996;3:205-14.
27. Oaklander AL, Romans K, Horasek S, Stocks A, Hauer P, Meyer RA. Unilateral postherpetic neuralgia is associated with bilateral sensory neuron damage. Ann Neurol 1998;44:789-95.
28. Oaklander AL. The density of remaining nerve endings in human skin with and without postherpetic neuralgia after shingles. Pain 2001;92:139-45.